Tonic Clonic Epilepsy Treatment Adjunct — Patent Landscape
1
Approved drugs
28
Active US patents
56/100
Avg vulnerability
—
Annual revenue covered
Originators in Tonic Clonic Epilepsy Treatment Adjunct
Cliff calendar — next 15 years
6
27
2
28
8
31
12
34
Approved drugs ranked by patent estate
| Drug | Originator | Active patents | Avg vuln | Revenue | First cliff |
|---|---|---|---|---|---|
|
Keppra
levetiracetam
|
Generic (originally UCB Pharma) | 28 | 56 | — | 2027-09-03 |
Most attackable patents
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 8802142 | Keppra | other | 68 | 2031-12-07 |
| 8802142 | Keppra | other | 68 | 2031-12-07 |
| 8802142 | Keppra | other | 68 | 2031-12-07 |
| 8802142 | Keppra | other | 68 | 2031-12-07 |
| 9669009 | Keppra | method of use | 62 | 2034-03-14 |
| 9669009 | Keppra | method of use | 62 | 2034-03-14 |
| 9339489 | Keppra | method of use | 62 | 2034-03-14 |
| 9339489 | Keppra | method of use | 62 | 2034-03-14 |
| 9339489 | Keppra | method of use | 62 | 2034-03-14 |
| 9669009 | Keppra | method of use | 62 | 2034-03-14 |
Strongest defences
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 11160786 | Keppra | formulation | 42 | 2034-03-14 |
| 11160786 | Keppra | formulation | 42 | 2034-03-14 |
| 11160786 | Keppra | formulation | 42 | 2034-03-14 |
| 11160786 | Keppra | formulation | 42 | 2034-03-14 |
| 8802142 | Keppra | formulation | 53 | 2031-06-07 |
| 8802142 | Keppra | formulation | 53 | 2031-06-07 |
| 8802142 | Keppra | formulation | 53 | 2031-06-07 |
| 8802142 | Keppra | formulation | 53 | 2031-06-07 |
| 8431156 | Keppra | formulation | 55 | 2027-10-31 |
| 8470367 | Keppra | formulation | 55 | 2027-10-31 |
Related
- Tonic Clonic Epilepsy Treatment Adjunct — full disease profile
- AI Patent Landscape Report — type "tonic clonic epilepsy treatment adjunct" for an AI exec memo
- Company Patent Rankings
- Biosimilar Opportunity Scanner